Search for: "Eli Lilly "
Results 2021 - 2040
of 2,131
Sorted by Relevance
|
Sort by Date
3 Apr 2019, 9:32 am
Eli Lilly (the Second Appellant), is the exclusive licensee. [read post]
10 Apr 2008, 3:08 am
Amici Briefs: Accenture: www.patentlyo.com/patent/bilski.accenture.pdf ACLU: [www.aclu.org] AIPLA: www.patentlyo.com/patent/bilski.aipla.pdf AMEX: www.patentlyo.com/patent/bilski.amex.pdf BIO: www.patentlyo.com/patent/bilski.bio.pdf BPLA: www.patentlyo.com/patent/bilski.bpla.pdf BSA: www.patentlyo.com/patent/bilski.bsa.pdf CCIA: [www.ccianet.org] CPA: www.patentlyo.com/patent/bilski.aicpa.pdf Dell & Microsoft: www.patentlyo.com/patent/bilski.microsoft.pdf EFF (Schultz)… [read post]
14 Nov 2023, 4:18 am
The judge considered these two differences collectively in determining whether PMI’s product infringed as an equivalent (the approach he endorsed in Regen v Estar[2]) under the 3-step test set out in Actavis v Eli Lilly[3]. [read post]
27 Dec 2007, 9:55 am
Eli Lilly & Co., 860 N.E.2d 884, 896 (Ind. [read post]
22 Oct 2024, 6:14 am
Lactalis American Group Indiana Industry Select data reports the following as the top factory worker employers in the Hoosier State: Eli Lilly & Co. [read post]
9 Nov 2015, 7:39 am
One of the great advantages of bifurcated patent litigation [perhaps the only advantage, wonders Merpel] is that bifurcated decisions make for shorter judgments and shorter blogposts to explain them. [read post]
23 Dec 2007, 8:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at [feeds.feedburner.com]GlobalEvents in Bali heap further pressure on all IP owners: (IAM),Velcro defies generic claim in domain name battle: (OUT-LAW),ICANN forms group to hasten non-English domain names: (IP Justice)WTO members continue debate on geographical indications register: (Intellectual Property Watch),Creative Commons launches CCo and CC programs: (World IP Day),Green IP Strategy - risks… [read post]
5 Jul 2011, 7:07 am
Here is the latest installment of Reexamination Requests from Scott Daniels, of Reexamination Alert and Practice Center Contributor… A10 Networks may have set a record last week when it requested reexamination of 13 Brocade patents involving global servers (see ex parte Request Nos. (2)-(3), (5)-(8), (11)-(17)). [read post]
20 Oct 2008, 5:39 pm
Why do I smile? [read post]
20 Dec 2023, 5:00 am
Major industry players filed amici briefs on both sides, AbbVie, Bristol Meyers Squibb, and Merck supporting Amgen, and Pfizer, Eli Lilly, Genentech, and AstraZeneca supporting Sanofi. [read post]
21 Jul 2010, 4:33 am
The Los Angeles Times featured a story about the legal saga that has enveloped the Christian bestseller The Shack: "The Shack," William Paul Young's novel about a man rediscovering lost faith after the murder of his 5-year-old daughter, started out as a manuscript no one would touch. [read post]
17 Apr 2008, 10:39 am
Eli Lilly & Co., 536 F. [read post]
15 Jun 2007, 9:09 am
Drugmaker Eli Lilly's proxy specifies that CEO Sidney Taurel only used the company jet for personal travel to and from outside board meetings. [read post]
18 Nov 2016, 12:44 am
The judge held that the “undue burden” concept in English law (particularly as outlined by Arnold J in Eli Lilly v Janssen in 2014) was not particularly helpful under Australian law. [read post]
5 Jul 2011, 7:07 am
Here is the latest installment of Reexamination Requests from Scott Daniels, of Reexamination Alert and Practice Center Contributor… A10 Networks may have set a record last week when it requested reexamination of 13 Brocade patents involving global servers (see ex parte Request Nos. (2)-(3), (5)-(8), (11)-(17)). [read post]
6 Oct 2011, 4:37 pm
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
28 Mar 2008, 7:25 am
Proponents have withdrawn resolutions at Abbott Laboratories, Aetna, Bristol-Myers Squibb, Eli Lilly, General Electric, IBM, Johnson & Johnson, McDonald's, Medco, WellPoint, ExxonMobil, Merck, Target, and Waste Management after many of the companies agreed to post statements on health care reform on their Web sites. [read post]
27 Oct 2011, 4:24 am
Eli Lilly paid $1.4 billion for Zyprexa marketing. [read post]
17 Jun 2010, 5:00 am
Eli Lilly & Co., 696 N.E.2d 187 (Ohio 1998)) and a gun case in New York (Hamilton v. [read post]
10 Aug 2012, 8:48 am
Reddy's Laboratories v Eli Lilly [2009] EWCA Civ 1362 where the judge, having reviewed the EPO jurisprudence on obviousness including Agrevo T 0939/92 stated: "The EPO jurisprudence is founded firmly around a fundamental question: has a patentee made a novel non-obvious technical advance and provided sufficient justification for it to be credible? [read post]
